CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Make Your Production Sites Adaptable And More Efficient

  Pharma faces mounting complexity and tighter margins, demanding agile, future-ready production. Discover how smart manufacturing enables faster adaptation and continuous therapy availability.

• How To Successfully Isolate Your T Cells

  Explore the results of a study focusing on the early stages of the CAR T cell workflow, specifically the initial washing of leukapheresis followed by the isolation of T cells.

• The Art Of Phosphitylation

  Phosphorylation is key for bioactives, with phosphoramidites favored for high selectivity. Discover how choosing specific protecting groups and new technologies fine-tunes the synthesis process.

• Detect Ultra-Rare Variants In cfDNA From Liquid Biopsy Samples

  Liquid biopsy, powered by next-generation sequencing, is transforming precision oncology to offer real-time, non-invasive insights into tumor genetics, which revolutionizes how we monitor and manage cancer.

• Background-Free Analysis Of Mouse TILs

  Syngeneic mouse tumor models are crucial for immunotherapy research, but variability in TILs and nonspecific binding complicate analysis. Discover how blocking reagents help but make the process more labor-intensive.

• Quality Assurance In IVT RNA Vaccine Development Using Electrophoresis

  Discover advanced solutions for IVT RNA synthesis, focusing on enhancing fidelity in throughput, innovative technologies, and methodologies to optimize your RNA research and development processes.

• Phase-Appropriate Approaches To Manufacturing And Testing

  Accelerate the development of high-quality biopharmaceuticals by implementing phase-appropriate, risk-based manufacturing and testing strategies that ensure timely progression.

• Scale-Up Of AAV Production In Fixed-Bed Bioreactors

  Consistent AAV production is critical for manufacturing. See how aligned strategies deliver comparable cell growth, metabolic trends, and rAAV5 titers from development through production.

• Understanding Immunogenicity In AAV Gene Therapy

  As adeno-associated virus-based gene therapies progress toward clinical use, effectively managing immunogenicity risk is critical to patient selection, therapeutic durability, and regulatory success.

• Lightning-Link^® Conjugation Kits: Consistent Performance On A Broad Scale

  Learn about labeling technology offering a transformative solution through direct antibody labeling without the need for post-conjugation purification, thereby mitigating antibody loss and ensuring reproducible results.